Endurance Wealth Management, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
Endurance Wealth Management, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2020$25,000
-10.7%
290
-10.8%
0.00%
-20.0%
Q2 2020$28,000
+3.7%
3250.0%0.01%0.0%
Q1 2020$27,000
-42.6%
325
-34.1%
0.01%
-28.6%
Q4 2019$47,000
+67.9%
493
+51.7%
0.01%
+40.0%
Q3 2019$28,000
-96.3%
325
-96.1%
0.01%
-95.8%
Q2 2019$760,000
+2351.6%
8,325
+2461.5%
0.12%
+2300.0%
Q1 2019$31,000
-91.6%
325
-92.5%
0.01%
-92.8%
Q4 2018$371,000
+12266.7%
4,325
+12257.1%
0.07%
Q3 2018$3,0000.0%350.0%0.00%
Q2 2018$3,000
-96.9%
35
-97.0%
0.00%
-100.0%
Q1 2018$96,000
-3.0%
1,1850.0%0.02%0.0%
Q4 2017$99,000
-2.9%
1,1850.0%0.02%
-5.9%
Q3 2017$102,000
+3.0%
1,1850.0%0.02%0.0%
Q2 2017$99,000
+12.5%
1,1850.0%0.02%
+13.3%
Q1 2017$88,000
+2.3%
1,1850.0%0.02%0.0%
Q4 2016$86,000
-6.5%
1,1850.0%0.02%
-6.2%
Q3 2016$92,000
-6.1%
1,1850.0%0.02%
-11.1%
Q2 2016$98,000
-18.3%
1,185
-28.4%
0.02%
+5.9%
Q1 2016$120,000
-15.5%
1,6550.0%0.02%
-37.0%
Q4 2015$142,000
-21.5%
1,655
-15.3%
0.03%
-15.6%
Q3 2015$181,000
-5.7%
1,9550.0%0.03%0.0%
Q2 2015$192,000
-34.0%
1,955
-33.8%
0.03%
-37.3%
Q1 2015$291,0002,9550.05%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders